Tarsus Pharmaceuticals Inc. (TARS)
Market Closed
27 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
60. 12
+1.46
+2.4889%
$
2.48B Market Cap
- P/E Ratio
- Div Yield
725,405 Volume
-4.18 Eps
$ 58.66
Previous Close 
Want to track TARS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tarsus Pharmaceuticals Inc. (TARS) Statistics
Valuation metrics
Market Cap 2.48B
Enterprise value 2.51B
Trailing P/E (ttm) -51.46
Forward P/E -
PEG ratio -0.51
Price/Sales (ttm) 4.72
Price/Book (mrq) 7.22
Enterprise Value/Revenue 4.69
Enterprise Value/EBITDA -62.47
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 446.49K
Average volume (90 days) 735.11K
Price summary
52-Week low 38.51
52-Week high 85.25
Beta -
50-Day moving average 61.5
200-Day moving average 67.17
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.09%
Operating margin -0.09%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 12.46
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.05
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 3.74%
Book value per share (mrq) 8.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
